Swedish Orphan Biovitrum
(OTCPK:BIOVF)
$22.87
0[0.00%]
At close: Apr 18
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About
Sector
Healthcare
Industry
N/A
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology....
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BIOVF

FAQ

Q

How do I buy Swedish Orphan Biovitrum (BIOVF) stock?

A

You can purchase shares of Swedish Orphan Biovitrum (OTCPK: BIOVF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Swedish Orphan Biovitrum's (BIOVF) competitors?

A

There are no as such competitors for Swedish Orphan Biovitrum.

Q

What is the target price for Swedish Orphan Biovitrum (BIOVF) stock?

A

The latest price target for Swedish Orphan Biovitrum (OTCPK: BIOVF) was reported by Barclays on Wednesday, February 24, 2021. The analyst firm set a price target for 0.00 expecting BIOVF to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Swedish Orphan Biovitrum (BIOVF)?

A

The stock price for Swedish Orphan Biovitrum (OTCPK: BIOVF) is $22.87 last updated April 18, 2024 at 1:26 PM EDT.

Q

Does Swedish Orphan Biovitrum (BIOVF) pay a dividend?

A

There are no upcoming dividends for Swedish Orphan Biovitrum.

Q

When is Swedish Orphan Biovitrum (OTCPK:BIOVF) reporting earnings?

A

Swedish Orphan Biovitrum does not have any upcoming earnings scheduled.

Q

Is Swedish Orphan Biovitrum (BIOVF) going to split?

A

There is no upcoming split for Swedish Orphan Biovitrum.

Q

What sector and industry does Swedish Orphan Biovitrum (BIOVF) operate in?

A

Swedish Orphan Biovitrum is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.